- Home
- CRMD vs FMNB Comparison
CRMD vs FMNB Comparison
Compare CRMD & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | FMNB |
|---|---|---|
| Founded | 2006 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.2M | 555.3M |
| IPO Year | 2009 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CRMD | FMNB |
|---|---|---|
| Price | $7.48 | $13.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | $14.83 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 959.5K | 297.2K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 4.73% |
| EPS Growth | ★ 780.00 | 18.85 |
| EPS | ★ 2.04 | 1.45 |
| Revenue | ★ $311,709,000.00 | $279,922,000.00 |
| Revenue This Year | $0.30 | $52.63 |
| Revenue Next Year | N/A | $8.28 |
| P/E Ratio | ★ $3.71 | $9.89 |
| Revenue Growth | ★ 617.03 | 3.89 |
| 52 Week Low | $6.13 | $12.23 |
| 52 Week High | $17.43 | $15.50 |
Technical Indicators
Market Signals| Indicator | CRMD | FMNB |
|---|---|---|
| Relative Strength Index (RSI) | 55.06 | 54.41 |
| Support Level | $7.05 | $12.99 |
| Resistance Level | $8.53 | $14.37 |
| Average True Range (ATR) | 0.28 | 0.33 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 46.77 | 29.53 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.